BOTOX® Cosmetic & Skin Health.

Clinical Trial Summary

This is a two cohort, randomized, double blind, single center study to evaluate the effects of Botox Cosmetic (BTX) on sebum protection. Thirty-four female subjects with moderate-to-high skin sebum concentration will be recruited and randomized in a 1:1 ratio to treatment groups.

See also
Status	Clinical Trial	Phase
Completed	`NCT04917835` - Non-thermal Plasma for Sebum Reduction in Oily Facial Skin	N/A
Completed	`NCT01640028` - Exploratory Study of Intra and Inter-subject Variability in Sebum Excretion Rate	N/A
Completed	`NCT01254162` - Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers	Phase 2
Completed	`NCT02597777` - Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04917835 - Non-thermal Plasma for Sebum Reduction in Oily Facial Skin

N/A

Completed

NCT01640028 - Exploratory Study of Intra and Inter-subject Variability in Sebum Excretion Rate

N/A

Completed

NCT01254162 - Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers

Phase 2

Completed

NCT02597777 - Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05138835
Study type	Interventional
Source	Erevna Innovations Inc.
Contact
Status	Completed
Phase	N/A
Start date	November 11, 2021
Completion date	December 11, 2022

BOTOX® Cosmetic and Skin Health.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms